AzTrials
AzTrials

HysterosalpingographyNCT05313373

The Effect of Virtual Reality on Women Undergoing Hysterosalpingography

A study testing Virtual Reality in people with Hysterosalpingography, run by NESLİHAN YILMAZ SEZER at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to determine the effect of virtual reality on perceived pain, anxiety, fear, physiological reactions and satisfaction in women during the HSG procedure. Hypotheses H01; In the HSG procedure, there was no difference between the pain score of the virtual reality group and the pain score of the… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Hysterosalpingography
What is being tested?
Virtual Reality
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
2 sitesTurkey (Türkiye)
Study dates
26 Apr 2022to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • primary infertility
  • Agreeing to participate in the research and obtaining written permission,
  • No hearing or vision problems
  • The first time HSG procedure will be applied

Who cannot join

  • Didn't watch the whole video
  • Those with motion-sensitive diseases such as vertigo, meniere
  • Using any pharmacological pain-reducing method within 30 minutes
  • Difficulty in the HSG process or completing the process with more than one attempt
  • Use of antidepressants or sedatives
  • Any history of allergy to radio-opaque dye

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Ankara University Fertility Diagnosis, Treatment, Research and Application Center

    Ankara, Mamak, 06100

  • Ankara University Fertility Diagnosis, Treatment, Research and Application Center

    Ankara, 06100

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality On Women's Perceptıons of Fear, Pain, Anxiety and Satisfaction Undergoing Hysterosalpingography; A Randomized Controlled Research

The aim of this study is to determine the effect of virtual reality on perceived pain, anxiety, fear, physiological reactions and satisfaction in women during the HSG procedure.

Hypotheses H01; In the HSG procedure, there was no difference between the pain score of the virtual reality group and the pain score of the control group.

Read more

H02; In the HSG procedure, there was no difference between the anxiety score of the virtual reality group and the anxiety score of the control group.

H03; In the HSG procedure, there was no difference between the satisfaction score of the virtual reality group and the satisfaction score of the control group.

H04; In the HSG procedure, there was no difference between the vital signs of the virtual reality group and the control group.

H05; In the HSG procedure, there was no difference between the fear score of the virtual reality group and the fear score of the control group.

The study will be carried out in two different groups. The practice will start with meeting the women who apply to the Radiology clinic for an HSG. After the women are evaluated in terms of eligibility criteria for the research, the women who are eligible will be informed about the research and written informed consent will be obtained from the women who accept. The random distribution of women to the study groups will be carried out using the Block Randomization method. The following applications will be made to the groups.

Virtual Reality Group In addition to the routine procedure, virtual reality glasses will be applied to the women in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After being taken to the gynecological table for the HSG procedure, the women included in the experimental group will be made to watch a video lasting an average of 10 minutes with virtual reality glasses until the procedure is completed. While watching the video, the relaxing music of the video will be played in the practice room with a bluetooth speaker.

Control Group Patients in the control group of the study will not be subjected to any treatment other than the routine procedure.

Being tested
Virtual Reality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual RealityOther

    In addition to the routine procedure, virtual reality glasses will be applied to the women in the virtual reality group of the research. Virtual reality glasses is a device that works on compatible smart mobile phones. After being taken to the gynecological table for the HSG procedure, the women included in the experimental group will be made to watch a video lasting an average of 10 minutes with virtual reality glasses until the procedure is completed. While watching the video, the relaxing music of the video will be played.

Study groups in NCT05313373
Study groupRoleWhat they receive
Virtual Reality GroupExperimentalNot described
Receives: Other: Virtual Reality
Control GroupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in anxiety

    STAI-S consist of 20 items with four points Likert scales, each (not at all, somewhat, moderately so, very much so). Scores thus range between 20, indicating a low level of anxiety and 80, indicating a high level.

    Measured: immediately before the HSG procedure and immediately after the HSG procedure

  2. Change in the degree of pain experienced during the procedure

    The pain was assessed using 0-100 mm VAS for determining perceptions of pain during the procedure. This scale is widely used and has demonstrated reliability and validity in the measurement of acute pain. A high score on the scale indicated a high level of pain and a score of 0 pointed to no pain at all (Bijur, Silver, \& Gallagher, 2001). Each participant was asked to mark her current level of perceived pain along the scale, with the number corresponding to the marked point recorded as the pain score

    Measured: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure

  3. Change in fear

    VAS is a 10-cm-long measurement tool. The left end of the scale reads "no fear at all" and the right end reads "the most intense fear possible". A high score on the scale indicated a high level of fear and a score of 0 pointed to no fear.

    Measured: immediately before the HSG procedure, immediately after the HSG procedure, and 15 minutes after the HSG procedure

Secondary outcomes (7)
  1. the degree of satisfaction

    VAS is a 10-cm-long measurement tool. The left end of the scale reads "I am not satisfied at all" and the right end reads "very satisfied". A high score on the scale indicated a high level of satisfied and a score of 0 pointed to no satisfied.

    Measured: 15 minutes after the HSG procedure

  2. Change in blood pressure

    mmHg

    Measured: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure

  3. Change in heart rate

    beats per minute (bpm)

    Measured: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure

  4. Change in body temperature

    degrees Celsius

    Measured: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure

  5. Change in the saturation of peripheral oxygen SpO2

    Measured: immediately before the HSG procedure, and immediately after the HSG procedure, and 15 minutes after the HSG procedure

  6. HSG result

    both tubes patent, one fallopian tubes occluded, both fallopian tubes occluded

    Measured: 15 minutes after the HSG procedure

  7. contrast medium volume

    milliliter (ml)

    Measured: during HSG prosedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Apr 2022
  2. Study start26 Apr 2022
  3. Primary completion30 Jun 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
62 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05313373
Sponsor's protocol ID
04/49
Status last verified
Jan 2023
First submitted
14 Mar 2022
Last updated
20 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality in people with Hysterosalpingography, run by NESLİHAN YILMAZ SEZER at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in anxiety (time frame: immediately before the HSG procedure and immediately after the HSG procedure). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in